Tag: Competition

Displaying 1361 - 1380 of 2722 results.

Pages

The FTC will hold hearings this fall to address whether there have been broad-based changes in the contemporary competitive environment that require any adjustments in antitrust and consumer protection enforcement in order to keep pace with those changes.
The Federal Trade Commission and Department of Justice will commence public hearings in Washington, D.C. on February 26, 2003 on the implications of competition law and policy for health care financing and delivery. The hearings will broadly consider the impact of competition law and...
FTC and DOJ hearings. The Antitrust Division and the Federal Trade Commission (FTC) cohosted hearings on single-firm conduct and antitrust law in 2006 and 2007. To see the Presentations, please visit DOJ's website: http://www.justice.gov/atr/public/hearings/single_firm/sfcjune.html...
The Federal Trade Commission issued final changes to the premerger notification rules that require companies in the pharmaceutical industry to report certain proposed acquisitions of exclusive patent rights to the FTC and the Department of Justice for antitrust review.
The Federal Trade Commission has unanimously voted to close its seven-month investigation into the proposed $1.2 billion merger of office supply superstores Office Depot, Inc. and OfficeMax, Inc. and has issued a Commission statement detailing the basis for its decision.
The Federal Trade Commission has approved a request by Kinder Morgan, Inc., that the Commission modify the final FTC order and approve a change to a related divestiture agreement.  The order resolved Commission charges that Kinder Morgan’s 2012 acquisition of El Paso Corporation would harm...
Under a settlement with th FTC, Mylan, Inc., and Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. (collectively, Agila)  divested 11 generic injectable drugs as a condition of allowing Mylan’s proposed acquisition of Agila from Strides Arcolab Ltd. (Strides)....
In light of the recent, temporary government shutdown, the Federal Trade Commission is extending the public comment periods for 13 matters that currently are pending before the agency in order to ensure that interested parties have a full opportunity to file comments.  The Commission also...
Following a public comment period, the Federal Trade Commission has approved a final order settling charges that Solera Holdings, Inc.’s 2012 purchase of rival Actual Systems of America, Inc. was anticompetitive. The FTC's complaint alleges that the acquisition significantly harmed competition in...
Under a settlement, the FTC required Watson Pharmaceuticals, Inc. and Actavis Inc.
Following an appeal by RealComp, the United States Court of Appeals for the Sixth Circuit upheld the FTC order. On August 15, 2011 Realcomp appealed to the Supreme Court. On October 11, 2011 the Supreme Court denied Realcomp's petition for a writ of certiorari.
There is a related administrative proceeding.
International drug manufacturer Actavis, Inc. has agreed to sell all rights and assets to four generic pharmaceuticals – three oral contraceptives and an osteoporosis treatment – to settle FTC charges that its proposed $8.5 billion acquisition of drug-maker Warner Chilcott plc would be...
Honeywell International Inc agreed to license patents critical to the manufacture of two-dimensional (2D) bar code scanners to settle FTC charges that it's acquisition of rival Intermed Inc would be anticompetitive.  Honeywell will license its and Intermec's patents for 2D scan...
Media research company Nielsen Holdings N.V. settled charges that its acquisition of Arbitron Inc. may substantially lessen competition for national syndicated cross-platform audience measurement services.  Nielsen and Arbitron are the best-positioned firms to develop (or partner with...
The Federal Trade Commission voted to seek public comments on a proposal to gather information from approximately 25 companies that are in the business of buying and asserting patents, known as Patent Assertion Entities (“PAEs”). The FTC intends to use this information to examine how PAEs do...
The Federal Trade Commission will require Mylan, Inc., and Agila Specialties Global Pte. Ltd and Agila Specialties Pvt. Ltd. (collectively, Agila) to divest 11 generic injectable drugs as a condition of allowing Mylan’s proposed acquisition of Agila from Strides Arcolab Ltd. (Strides).

Pages